Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02138292
What this trial is testing

A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma

Who this might be right for
Melanoma
University of Texas Southwestern Medical Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT06414590
What this trial is testing

Neoadjuvant Tebentafusp for Uveal Melanoma

Who this might be right for
Locally Advanced Unresectable Uveal Melanoma
Thomas Jefferson University 19
Not applicableLooking for participantsNCT03116412
What this trial is testing

Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

Who this might be right for
Malignant Melanoma
Uppsala University 1,300
Testing effectiveness (Phase 2)Looking for participantsNCT05144698
What this trial is testing

RAPA-201 Therapy of Solid Tumors

Who this might be right for
Solid TumorSmall Cell and Non-small Cell Lung CancerHead and Neck Cancer+6 more
Rapa Therapeutics LLC 37
Testing effectiveness (Phase 2)Study completedNCT00466687
What this trial is testing

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma
Vanderbilt-Ingram Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00084214
What this trial is testing

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Who this might be right for
Melanoma
Synta Pharmaceuticals Corp. 103
Not applicableStudy completedNCT04576416
What this trial is testing

Artificial Intelligence Augmented Training in Skin Cancer Diagnostics for General Practitioners

Who this might be right for
MelanomaSkin Cancer
Herlev Hospital 115
Large-scale testing (Phase 3)Looking for participantsNCT06008106
What this trial is testing

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Who this might be right for
Melanoma
Shanghai Kechow Pharma, Inc. 165
Not applicableStudy completedNCT00597272
What this trial is testing

Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 34
Early research (Phase 1)Study completedNCT01639911
What this trial is testing

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastCNS MalignancyMalignant Neoplasm of Gastrointestinal Tract+4 more
University of Illinois at Chicago 28
Early research (Phase 1)Study completedNCT01456104
What this trial is testing

Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)WithdrawnNCT01416844
What this trial is testing

Study of Immune Responses in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Providence Health & Services
Not applicableStudy completedNCT04969419
What this trial is testing

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

Who this might be right for
VitiligoMelanoma (Skin)Nonmelanoma Skin Cancer+3 more
Momentum Data 75,771
Testing effectiveness (Phase 2)Ended earlyNCT01271907
What this trial is testing

Drosophila-generated CTL

Who this might be right for
Metastatic Cutaneous Melanoma
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT02392871
What this trial is testing

Radiotherapy & Combi in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Melanoma and Skin Cancer Trials Limited 10
Early research (Phase 1)Ended earlyNCT01940809
What this trial is testing

Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Melanoma+5 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Testing effectiveness (Phase 2)WithdrawnNCT00535314
What this trial is testing

Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Biogen
Testing effectiveness (Phase 2)Study completedNCT01961115
What this trial is testing

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Fred Hutchinson Cancer Center 11
Not applicableUnknownNCT06321640
What this trial is testing

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Who this might be right for
Breast CancerLung CancerMelanoma+5 more
European Institute of Oncology 265
Next Page